milrinone has been researched along with iloprost in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 6 (42.86) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 2 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Gill, J; Jeremy, JY; Mikhailidis, D | 1 |
| Heintz, B; Kirsten, D; Kirsten, R; Nelson, K | 1 |
| Arendshorst, WJ; Purdy, KE | 1 |
| Ravishankar, C; Tabbutt, S; Wernovsky, G | 1 |
| Autschbach, R; Buhre, W; de Waal, EE; Flier, S; Metzelder, S; Rex, S; Rossaint, R; Schaelte, G | 1 |
| Adderley, S; Bowles, EA; Hanson, MS; Sprague, RS; Sridharan, M; Stephenson, AH | 1 |
| Chen, B; Farrow, KN; Gugino, SF; Kumar, VH; Lakshminrusimha, S; Porta, NF; Russell, JA; Steinhorn, RH | 1 |
| Dakshinamurti, S; Elkhateeb, O; Halayko, AJ; Nolette, N; Outbih, O; Santhosh, KT | 1 |
| Boyanova, D; Dandekar, T; Dittrich, M; Geiger, J; Hubertus, K; Mischnik, M; Philippi, N; Timmer, J; Wangorsch, G | 1 |
| Jennings, DL; Moretz, JD; Sabato, LA; Salerno, DM | 1 |
| Antoniou, T; Leontiadis, E; Perreas, K; Rellia, P; Thanopoulos, A; Theodoraki, K; Zarkalis, D | 1 |
| Anstey, J; Boggett, S; Chun-Ting, W; Hu, X; Li, X; Royse, A; Royse, C; Yang, Y | 1 |
| Chartan, CA; Coleman, RD; Mourani, PM | 1 |
4 review(s) available for milrinone and iloprost
| Article | Year |
|---|---|
Clinical pharmacokinetics of vasodilators. Part II.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Alprostadil; Amrinone; Carbazoles; Carvedilol; Enoximone; Female; Humans; Iloprost; Imidazoles; Indoramin; Isosorbide Dinitrate; Labetalol; Milrinone; Molsidomine; Nitroglycerin; Nitroprusside; Oxyfedrine; Pentaerythritol Tetranitrate; Phosphodiesterase Inhibitors; Piperazines; Prazosin; Pregnancy; Propanolamines; Pyridones; Theophylline; Trapidil; Vasodilator Agents | 1998 |
Critical care in cardiovascular medicine.
Topics: Cardiac Output, Low; Cardiac Surgical Procedures; Cardiotonic Agents; Child; Critical Care; Dye Dilution Technique; Heart-Assist Devices; Humans; Hypertension, Pulmonary; Iloprost; Intraoperative Care; Milrinone; Phosphodiesterase Inhibitors; Piperazines; Purines; Sildenafil Citrate; Sulfones; Vasodilator Agents | 2003 |
Inhaled Pulmonary Vasodilator Therapy for Management of Right Ventricular Dysfunction after Left Ventricular Assist Device Placement and Cardiac Transplantation.
Topics: Administration, Inhalation; Heart Transplantation; Heart-Assist Devices; Humans; Iloprost; Milrinone; Nitric Oxide; Postoperative Period; Vasodilator Agents; Ventricular Dysfunction, Right | 2017 |
Intensive care management of right ventricular failure and pulmonary hypertension crises.
Topics: Biomarkers; Capnography; Central Venous Pressure; Critical Care; Echocardiography; Epinephrine; Epoprostenol; Extracorporeal Membrane Oxygenation; Heart Failure; Heart Ventricles; Humans; Hypertension, Pulmonary; Iloprost; Intensive Care Units; Milrinone; Nitric Oxide; Radiography, Thoracic; Respiration, Artificial; Spectroscopy, Near-Infrared; Vasodilator Agents; Vasopressins; Ventricular Dysfunction, Right; Ventricular Function, Right | 2021 |
1 trial(s) available for milrinone and iloprost
| Article | Year |
|---|---|
Inhaled iloprost to control pulmonary artery hypertension in patients undergoing mitral valve surgery: a prospective, randomized-controlled trial.
Topics: Administration, Inhalation; Aged; Cardiac Output, Low; Cardiopulmonary Bypass; Catheterization, Swan-Ganz; Echocardiography, Transesophageal; Female; Humans; Hypertension, Pulmonary; Iloprost; Infusions, Intravenous; Male; Middle Aged; Milrinone; Mitral Valve Insufficiency; Monitoring, Intraoperative; Nitroglycerin; Postoperative Complications; Prospective Studies; Stroke Volume; Vascular Resistance; Vasodilator Agents; Ventricular Dysfunction, Right | 2008 |
9 other study(ies) available for milrinone and iloprost
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Effect of milrinone on thromboxane A2 synthesis, cAMP phosphodiesterase and 45Ca2+ uptake by human platelets.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Blood Platelets; Calcium; Drug Interactions; Humans; Iloprost; In Vitro Techniques; Milrinone; Phosphodiesterase Inhibitors; Platelet Aggregation Inhibitors; Pyridones; Thromboxane A2 | 1993 |
Iloprost inhibits inositol-1,4,5-trisphosphate-mediated calcium mobilization stimulated by angiotensin II in cultured preglomerular vascular smooth muscle cells.
Topics: Angiotensin II; Animals; Calcium; Calcium Channels, L-Type; Calcium-Transporting ATPases; Carbazoles; Cells, Cultured; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Iloprost; Indoles; Inositol 1,4,5-Trisphosphate; Kidney Glomerulus; Milrinone; Muscle, Smooth, Vascular; Phosphodiesterase Inhibitors; Pyrroles; Rats; Thapsigargin | 2001 |
Phosphodiesterase 3 is present in rabbit and human erythrocytes and its inhibition potentiates iloprost-induced increases in cAMP.
Topics: Adult; Aged; Animals; Blotting, Western; Cilostazol; Cyclic AMP; Cyclic Nucleotide Phosphodiesterases, Type 1; Cyclic Nucleotide Phosphodiesterases, Type 3; Drug Interactions; Erythrocyte Membrane; Female; Humans; Iloprost; Male; Middle Aged; Milrinone; Phosphodiesterase 3 Inhibitors; Phosphodiesterase Inhibitors; Quinolones; Rabbits; Tetrazoles; Up-Regulation | 2008 |
Milrinone enhances relaxation to prostacyclin and iloprost in pulmonary arteries isolated from lambs with persistent pulmonary hypertension of the newborn.
Topics: Animals; Animals, Newborn; Blotting, Western; Disease Models, Animal; Drug Interactions; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Epoprostenol; Female; Hypertension, Pulmonary; Iloprost; Male; Milrinone; Pregnancy; Pregnancy, Animal; Probability; Pulmonary Artery; Random Allocation; Reference Values; Sensitivity and Specificity; Sheep, Domestic; Vasodilation | 2009 |
Milrinone attenuates thromboxane receptor-mediated hyperresponsiveness in hypoxic pulmonary arterial myocytes.
Topics: Animals; Animals, Newborn; Calcium; Cells, Cultured; Cyclic AMP-Dependent Protein Kinases; Iloprost; Inositol 1,4,5-Trisphosphate; Milrinone; Myocytes, Smooth Muscle; Oxygen; Pulmonary Artery; Receptors, Thromboxane; Signal Transduction; Swine; Vasodilator Agents | 2011 |
A Boolean view separates platelet activatory and inhibitory signalling as verified by phosphorylation monitoring including threshold behaviour and integrin modulation.
Topics: Aspirin; Blood Platelets; Cardiovascular Diseases; Clopidogrel; Hemorrhage; Humans; Iloprost; Integrins; Milrinone; Models, Biological; Molecular Dynamics Simulation; Phosphorylation; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Proto-Oncogene Proteins c-akt; Signal Transduction; Ticlopidine | 2013 |
A retrospective comparison of inhaled milrinone and iloprost in post-bypass pulmonary hypertension.
Topics: Administration, Inhalation; Aged; Aged, 80 and over; Arterial Pressure; Cardiopulmonary Bypass; Dose-Response Relationship, Drug; Echocardiography, Transesophageal; Female; Follow-Up Studies; Heart Diseases; Humans; Hypertension, Pulmonary; Iloprost; Male; Middle Aged; Milrinone; Postoperative Complications; Retrospective Studies; Treatment Outcome; Vascular Resistance; Vasodilator Agents | 2017 |
Routine Intraoperative Inhaled Milrinone and Iloprost Reduces Inotrope Use in Patients Undergoing Cardiac Surgery: A Retrospective Cohort Pilot Study.
Topics: Administration, Inhalation; Aged; Cardiac Surgical Procedures; Cardiotonic Agents; Cohort Studies; Female; Humans; Iloprost; Intraoperative Care; Intraoperative Complications; Male; Middle Aged; Milrinone; Myocardial Contraction; Pilot Projects; Retrospective Studies; Vasodilator Agents | 2020 |